The pandemic reinforced the importance of manufacturing, but we need to think beyond the local market towards exports. There is a new understanding of the pharma…
In Conversation
Making medicines available to patients is the name of the game because, in the past, the region had to wait years to get medications from Europe…
A pro-innovation policy environment will bring access to new medicines and encourage investment in Saudi Arabia while reducing barriers for companies to expand and thrive in…
Brazilian companies have shown great interest in entering Saudi Arabia, and the feeling is mutual.
With a clear vision and the imposition of privatization [in the Arab world], many opportunities have emerged for foreign companies to participate in tenders and gain…
SFDA has been developing very fast over the past couple of years and our future is even more promising. We are improving our regulations and processes…
Today, we are the only laboratory in Morocco exclusively dedicated to women’s and children’s well-being, supporting women through the different stages of their life and helping…
Any business relationship must be based on trust, aiming towards a win-win approach. If that is present, the sky is the limit
Sub-Saharan Africa has huge potential, with the population expected to increase by more than one billion by 2050.
We want to see the emergence of an ecosystem of clinical research and position Morocco as an expert hub like other countries such as Tunisia, Egypt…
In order to achieve sustained double-digit growth, we need to invest in training, education, awareness and work hand in hand with physicians to identify the right…
Today, we are independent and self-reliant since we can register our in-house products and out-license them to other pharma companies for additional marketing authorizations
